CPI Aerostructures Inc. (CVU) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

Per the Roarable RQD rating, CVU scores 28 out of 100 with a letter grade of E, labeled "Roarable Strong Sell — Forensic Risk / Avoid." The five pillars are:

• Fundamental Cash Engine (3 / 20): Return on invested capital is -0.5% and FCF yield is -8.01%. The cash-generation pillar is nearly exhausted, indicating the business is not currently producing free cash returns relative to its market value.
• Whale 13F Flow (10 / 20): Institutional accumulation and options positioning receive a middling score. This is the strongest pillar but still sits at half weight.
• Insider Conviction (3 / 20): SEC Form 4 and Congressional PTR cluster flow scores poorly, signaling weak insider conviction in the stock.
• Macro Regime Fit (8 / 20): Beta of 1.0 and sector sensitivity produce a below-midpoint score; the stock tracks the market without a clear macro tailwind in the source data.
• Forensic Balance Sheet (4 / 20): Altman Z-Score of 1.12, Piotroski F-Score of 1/9, and Debt/Equity of 0.5. The Altman and Piotroski readings are weak, which is the primary driver of the forensic risk flag.

For a prospective investor evaluating the stock today, the upside drivers are limited to the institutional-flow pillar and the modest recent price action ($4.96, +1.02%, within a $2.02–$5.98 52-week range). The valuation tradeoff is stark: with negative free cash flow yield, negative ROIC, and a distressed-range Altman Z-Score, the market price is not supported by current cash generation as reflected in this rating. The rating's conclusion is that downside forensic risk outweighs the stock's near-term price momentum.

Per the SEC financials, revenue declined from $86.5M (FY 2023) to $81.1M (FY 2024) to $69.3M (FY 2025), and operating income moved from $6.3M to $6.7M to $-0.2M. Per the market data, gross margin is 15.2%, operating margin -0.3%, and net margin -1.2%. ROIC is -0.5%. Per the Roarable RQD rating, the Altman Z-Score is 1.12, the Piotroski F-Score is 1/9, and Debt/Equity is 0.5; these are the forensic readings cited in the rating. Cash and debt balances are N/A in the financials.

• What are the company's cash and debt balances, which are N/A in the financials, and how do they reconcile with the Debt/Equity reading of 0.5?
• What drove the decline in operating income from $6.7M in FY 2024 to $-0.2M in FY 2025, and is the revenue decline from $81.1M to $69.3M concentrated in specific programs or customers?
• What are the transaction details (size, price, and shares) of the Form 4 filing attributed to Pamela Levesque, and do they represent open-market buying or selling?
• What are the sources of the institutional-flow score (10/20), given that 13F holder data is listed as NONE in the source data?
• Which customers, programs, and supply-chain relationships underpin the Military/Government/Technical exposure, given the Butterfly graph lists no links?